Z86.00A Medicare coverage policies

24 active Medicare policies list Z86.00A. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.

Get free alerts for Z86.00A

Free account. Policy pages stay open to everyone.

Medicare policies listing Z86.00A

LCD · FIRST_COAST-L36499

BRCA1 and BRCA2 Genetic Testing

J9 · Effective Apr 11, 2016

LCD · NOVITAS-JH-L36715

BRCA1 and BRCA2 Genetic Testing

JH · Effective Dec 1, 2016

LCD · NOVITAS-JL-L36715

BRCA1 and BRCA2 Genetic Testing

JL · Effective Dec 1, 2016

LCD · PALMETTO-JJ-L34417

CT of the Head

JJ · Effective Oct 1, 2015

LCD · PALMETTO-JM-L34417

CT of the Head

JM · Effective Oct 1, 2015

LCD · NGS-J6-L33394

Drugs and Biologicals, Coverage of, for Label and Off-Label Uses

J6 · Effective Oct 1, 2015

LCD · NGS-JK-L33394

Drugs and Biologicals, Coverage of, for Label and Off-Label Uses

JK · Effective Oct 1, 2015

LCD · FIRST_COAST-L34912

Genetic Testing for Lynch Syndrome

J9 · Effective Oct 1, 2015

LCD · CGS-J15-L39017

MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer

J15 · Effective Aug 21, 2022

LCD · NORIDIAN-JE-L38972

Z86.00A Medicare coverage policies

Medicare policies listing Z86.00A

BRCA1 and BRCA2 Genetic Testing

BRCA1 and BRCA2 Genetic Testing

BRCA1 and BRCA2 Genetic Testing

CT of the Head

CT of the Head

Drugs and Biologicals, Coverage of, for Label and Off-Label Uses

Drugs and Biologicals, Coverage of, for Label and Off-Label Uses

Genetic Testing for Lynch Syndrome

MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer

MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer

Z86.00A Medicare coverage policies

Medicare policies listing Z86.00A

BRCA1 and BRCA2 Genetic Testing

BRCA1 and BRCA2 Genetic Testing

BRCA1 and BRCA2 Genetic Testing

CT of the Head

CT of the Head

Drugs and Biologicals, Coverage of, for Label and Off-Label Uses

Drugs and Biologicals, Coverage of, for Label and Off-Label Uses

Genetic Testing for Lynch Syndrome

MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer

MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer

MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer

MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer

MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer

MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer

MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer

Billing and Coding: BRCA1 and BRCA2 Genetic Testing

Billing and Coding: Bevacizumab and biosimilars

Billing and Coding: BRCA1 and BRCA2 Genetic Testing

Billing and Coding: CT of the Head

Billing and Coding: Genetic Testing for Lynch Syndrome

Billing and Coding: MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer

Billing and Coding: MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer

Billing and Coding: MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer

Billing and Coding: MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer